These 6 companies are using AI to streamline clinical trials for pharma
Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.
Related Articles
AI and Automation Trends 2025 Report | UiPath
Download this report to learn the many possibilities AI and automation offers, and the steps you need to take to take advantage of them.
Quickbase Just Earned a Spot in the Top 5 AI Construction…
This recognition is more than just a badge of honor—it’s a sign that our platform is making a real difference for teams like yours. Whether…
Apple broadens research ambitions, unveils large-scale study into physical, mental health
More than five years ago, Apple launched thr | Apple is broadening its health research ambitions to use its devices, including iPhones, Apple Watch and…
Bacterial transfer during sexual intercourse as a tool for forensic detection
Biological sciences; Microbiome
Judge Temporarily Blocks Trump Cuts to Medical Research Funding
A coalition of 22 attorneys general sued the federal government, claiming that the $4 billion in cuts would “grind to a halt” studies on cancer,…
Just a small rise in global temperatures could be deadly
As early as mid-century, an area of land that adds up to the size of the U.S. could hit temperatures hazardous for human health.
How do doctors manage physical activity advocacy for patients and their own self-care? A qualitative interview study of general practitioners in Ireland
Objectives This study explored general practitioners’ (GPs) understanding of physical activity advocacy to patients and their own self-care, how GPs perceive their own physical activity…
Trump policies spark fears of brain drain, threatening to undermine U.S. dominance in biomedicine
A torrent of Trump administration policies is alarming scientists who fear the current climate is weakening researchers’ resolve to stick with careers in academic science.
Gomekli Approved for NF1-Associated Plexiform Neurofibromas
Mirdametinib is an inhibitor of mitogen-activated protein kinase kinases 1 and 2.
Child Health Care at a Crossroads—A Report From the National Academies of Sciences, Engineering, and Medicine
This Viewpoint discusses changes needed at local, state, and national levels to improve child health care.
